BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32069066)

  • 1. All Insulin Pumps Are Not Equivalent: A Bench Test Assessment for Several Basal Rates.
    Girardot S; Jacquemier P; Mousin F; Rendekeu C; Hardy S; Riveline JP
    Diabetes Technol Ther; 2020 Jun; 22(6):476-483. PubMed ID: 32069066
    [No Abstract]   [Full Text] [Related]  

  • 2. Kalman Filter-Based Novel Methodology to Assess Insulin Pump Accuracy.
    Girardot S; Mousin F; Vezinet J; Jacquemier P; Hardy S; Riveline JP
    Diabetes Technol Ther; 2019 Oct; 21(10):557-565. PubMed ID: 31335164
    [No Abstract]   [Full Text] [Related]  

  • 3. Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studies.
    Borot S; Franc S; Cristante J; Penfornis A; Benhamou PY; Guerci B; Hanaire H; Renard E; Reznik Y; Simon C; Charpentier G;
    J Diabetes Sci Technol; 2014 Nov; 8(6):1133-41. PubMed ID: 25079676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion (CSII) pumps.
    Valla V
    Adv Exp Med Biol; 2012; 771():414-9. PubMed ID: 23393693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
    Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
    Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
    Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents.
    Ziegler R; Waldenmaier D; Kamecke U; Mende J; Haug C; Freckmann G
    Pediatr Diabetes; 2020 Jun; 21(4):649-656. PubMed ID: 32003490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems.
    Freckmann G; Kamecke U; Waldenmaier D; Haug C; Ziegler R
    Diabetes Technol Ther; 2019 Apr; 21(4):201-208. PubMed ID: 30901232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro stability of insulin lispro in continuous subcutaneous insulin infusion.
    DeFelippis MR; Bell MA; Heyob JA; Storms SM
    Diabetes Technol Ther; 2006 Jun; 8(3):358-68. PubMed ID: 16800757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siphon effects on continuous subcutaneous insulin infusion pump delivery performance.
    Zisser HC; Bevier W; Dassau E; Jovanovic L
    J Diabetes Sci Technol; 2010 Jan; 4(1):98-103. PubMed ID: 20167172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes.
    Leelarathna L; Roberts SA; Hindle A; Markakis K; Alam T; Chapman A; Morris J; Urwin A; Jinadev P; Rutter MK
    Diabet Med; 2017 Oct; 34(10):1372-1379. PubMed ID: 28636773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative dose accuracy of durable and patch insulin infusion pumps.
    Jahn LG; Capurro JJ; Levy BL
    J Diabetes Sci Technol; 2013 Jul; 7(4):1011-20. PubMed ID: 23911184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps.
    Kamecke U; Waldenmaier D; Haug C; Ziegler R; Freckmann G
    J Diabetes Sci Technol; 2019 Jan; 13(1):60-67. PubMed ID: 30003823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus.
    Zisser HC; Bevier WC; Jovanovic L
    Diabetes Technol Ther; 2007 Dec; 9(6):509-15. PubMed ID: 18034605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons.
    Thabit H; Hovorka R
    Expert Opin Drug Deliv; 2016; 13(3):389-400. PubMed ID: 26618219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.